This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies Find out more here
U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.